MOZOM-analyse
MOZOM analyses: WHO Pandemic Agreement PABS, virus sharing or vaccine power?
- Source
- WHO, IGWG7, WHA78.1 en ontwerptekst PABS Annex
- MOZOM headline
- MOZOM analyses: WHO Pandemic Agreement PABS, virus sharing or vaccine power?
- Original headline
- Seventh meeting of the Intergovernmental Working Group on the WHO Pandemic Agreement starts negotiations on the PABS annex
- Author
- Paul Giezen
- Date
- 6 juli 2026 om 03:43
- Subject
- MOZOM investigates why the WHO negotiations from July 6 to 17, 2026 on PABS are not only about rapid virus division, but also about access to vaccines, tests, treatments, data and power in the next pandemic.
Summary of the original report
According to WHO, the seventh session of the Intergovernmental Working Group on the WHO Pandemic Agreement will run from July 6 to 17, 2026 in a hybrid format in Geneva. The core is the PABS annex: Pathogen Access and Benefit-Sharing. This annex should regulate how countries quickly share pathogens with pandemic potential, associated material and sequence information, and how the benefits are returned more fairly. The WHO places PABS as a missing final piece of the Pandemic Agreement that the World Health Assembly adopted on May 20, 2025. Only after the PABS annex has been adopted can the full agreement be open for signature and ratification, according to the WHO. The agreement text states that participating manufacturers must release rapid access to WHO in the event of a pandemic emergency, targeting 20 percent of their real-time production of safe and effective vaccines, therapeutics and diagnostics; at least 10 percent of it as a donation and the rest at affordable prices. The draft annex shows how technical and political this will be: physical samples, DNA/RNA sequences, recognized databases, laboratory networks, contracts with manufacturers, legal certainty, biosecurity, data protection, licensing, technology transfer and financial contributions.
Own source research
MOZOM has placed four source layers next to each other. Layer one is the current meeting: IGWG7 runs from July 6 to 17, 2026 and has PABS as a priority. Layer two is the May 1 update: member states made progress, but needed more time because the annex is technically and legally difficult. Layer three is Article 12 of the WHO Pandemic Agreement: it states that PABS must become a multilateral system for safe, transparent and accountable access to PABS materials and sequence information, while at the same time fair benefit-sharing. Layer four is the design annex: it shifts from political language to implementation questions such as which labs are allowed to share, which databases are recognized, how unique identifiers work, which contracts manufacturers sign and what technology transfer or licensing looks like. The own MOZOM layer: the real tension is not in the question of whether sharing is useful, but in the order. Many countries are not willing to fully trust rapid pathogen sharing until the return flow of vaccines, diagnostics, treatments and knowledge feels just as enforceable.
Striking in this message
It is striking that the same system can call up two completely different frames. For proponents, PABS is a correction to the corona period: no rapid data flow to the world without fairer access to products. To critics, it may sound like an extra international layer on top of national biosecurity, data protection and industrial policy. The WHO is trying to dampen this by emphasizing that the agreement respects national sovereignty and does not give WHO the authority to impose measures such as lockdowns or vaccination obligations on countries.
Less visible context
What is less visible is that pathogens today are biological, digital and commercial at the same time. There is a physical sample, but also sequence information that can travel through databases very quickly. There are public health benefits, but also intellectual property, production lines, export controls and scarcity in the first months of a crisis. As a result, PABS is not only about trust between countries, but also about trust between public laboratories, private manufacturers, databases and health authorities.
Possible message behind the news
A possible message is that the next pandemic can be slowed down more quickly if countries share sooner and manufacturers know in advance what benefits they have to give back. The critical counter-reading is that fairness only becomes visible when the contracts, production percentages, licenses and distribution rules not only sound nice, but also work in times of crisis.
Neutral conclusion
The neutral conclusion: WHO member states will continue to negotiate the PABS annex from July 6 to 17, 2026, the missing part that must allow the Pandemic Agreement to start legally and practically. The sharper MOZOM lecture: PABS is the test of whether the world can share a new virus more quickly without repeating the same battle over who will receive the vaccines, tests and treatments first.